# Retrospective Observational Study to Define HBsAg Loss With or Without Seroconversion to antiHBs in Patients With Chronic Hepatitis by B Virus Treated With Nucleoside/Nucleotide Analogs

> **NCT02005146** · — · COMPLETED · sponsor: **Fundación Pública Andaluza Progreso y Salud** · enrollment: 86 (actual)

## Conditions studied

- Chronic Hepatitis B Treated With Nucleoside/Nucleotide Analogues

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02005146
- **Lead sponsor:** Fundación Pública Andaluza Progreso y Salud
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2013-12
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 86 (ACTUAL)
- **Last updated:** 2015-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02005146

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02005146, "Retrospective Observational Study to Define HBsAg Loss With or Without Seroconversion to antiHBs in Patients With Chronic Hepatitis by B Virus Treated With Nucleoside/Nucleotide Analogs". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02005146. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*